pharma · Diabetes Mellitus · Hemophilia A
Takeda
NovaPharmaNews editorial coverage mentioning Takeda — regulatory, clinical, and market analysis.
Company details
- Status
- Public
- HQ
- Cambridge, USA
- Founded
- 1993
- Employees
- 1,617
- Programs
- 1179
- Drugs
- 359
- Patents
- 1436
News & analysis
NovaPharmaNews articles mentioning Takeda — regulatory, clinical, and market coverage.
NovaPharmaNews editorial coverage mentioning Takeda — regulatory, clinical, and market analysis.
Merck-Kelun ADC's Strategic Wins and Takeda's Antitrust Loss
This article delves into Merck-Kelun ADC's recent achievements in China and the implications of Takeda's significant antitrust loss, providing strategic insights for business development teams and investors.
Takeda's $885M Verdict: Implications for Pharma Business Strategies
Takeda faces an $885M verdict in a pay-for-delay antitrust case, raising significant questions for pharmaceutical business strategies and market dynamics.
Takeda Settles Kickback Allegations: What It Means for Pharma
Takeda has agreed to a $13.6 million settlement regarding allegations of kickbacks to doctors. This article explores the implications for the pharmaceutical sector.
Biotech Leaders Push for Pazdur Amid Takeda Layoffs
Biotech leaders are rallying for Pazdur's approval while Takeda announces significant layoffs. This article explores the implications for the pharma industry.